converting between glp-1 agonists TrimRX PDF] Switching Between Glucagon-Like Peptide-1

In one study, diabetes mellitus (DM), hypertension, and cardio-cerebrovascular diseases were found to be 23 times higher in intensive care unit (ICU)/severe cases compared to non-ICU/severe cases

Patients should not adjust doses without medical supervision, and healthcare teams remain the best resource for exploring whether this approach is appropriate

Common adverse reactions included nausea, diarrhea, and vomiting

Talk to a health care professional for personalized guidance

Its likely related to a finding that Camilleri and other researchers have repeatedly shown, which is that GLP-1 agonists slow down gastric emptying, the amount of time it takes the stomach to empty its contents into the small intestine (3)

doi: 10.1111/j.1432-1033.1994.1151b.x 45 GallwitzBWittMMorys-WortmannCFlschURSchmidtWE